Altering AAV tropism with mosaic viral capsids
Authors:
- Patricia RebolloPRPatricia Rebollo
- Nathalie ClementNCNathalie Clement
- Kenneth H. WarringtonKWKenneth H. Warrington
- Nicholas MuzyczkaNMNicholas Muzyczka
- R. Michael LindenRLR. Michael Linden
- Thomas WeberTWThomas Weber
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (6) , 856-865
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cross-Dressing the Virion: the Transcapsidation of Adeno-Associated Virus Serotypes Functionally Defines SubgroupsJournal of Virology, 2004
- Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface ReceptorsJournal of Virology, 2002
- Efficient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem CellsJournal of Virology, 2001
- Insertional Mutagenesis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors Targeted to Alternative Cell-Surface ReceptorsHuman Gene Therapy, 2001
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001
- Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacyGene Therapy, 1999
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus VectorsExperimental Neurology, 1998
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970